PROTEOSTASIS THERAPEUTICS, INC. 4
4 · PROTEOSTASIS THERAPEUTICS, INC. · Filed Feb 12, 2016
Insider Transaction Report
Form 4
Kelly Jeffrey W.
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-02-10+45,760→ 45,760 totalExercise: $8.00Exp: 2026-02-10→ Common Stock (45,760 underlying)
Footnotes (1)
- [F1]These securities shall vest and become exercisable in equal quarterly installments starting on February 10, 2016 until the option is fully vested and exercisable on February 10, 2019, subject to continued service.